Sitemap
En
Features
Current Location: Home > Features > Investment Update Briefing

No.7 Jan. 4th-Jan. 16th

No.7World’s Biggest EPS Producer Project Settles down in TEDA
Presenter
Deng Xiaoxuan

Interpreter in Steering Office of Commerce and Investment Promotion (Translation & Interpretation Center)

MOTECH Ranks among Top Ten in an Authoritative List


Recently, Top 100 Intellectual Property Values of Listed Companies on ChiNext has been released. With the research and development of membrane technology and intellectual property protection and management of core technology, Tianjin Motimo Membrane Technology Co., Ltd. ranks among the top ten, being the only enterprise listed in Tianjin.

TEDA Companies Rank among the Top 500 Chinese Listed Companies


Recently, the list of top 500 Chinese listed companies by market value has been released. Asymchem Life Science (Tianjin) Co., Ltd., CanSino Biologics Inc. and Tingyi Holding Corp. are on the list. Asymchem Life Science (Tianjin) Co., Ltd. is a leading CDMO company worldwide. Tingyi Holding Corp. is a leader in Tianjin and even the whole country in food industry. CanSino Biologics Inc. is an innovative biopharmaceutical company nationwide.

World’s Biggest EPS Producer Project Settles down in TEDA


Recently, Loyal Group, the world’s biggest EPS producer, has signed an investment cooperation agreement with TEDA. It plans to invest about 128 million US dollars in Nangang Industrial Zone to build a 400,000-ton expandable polystyrene (EPS) project. After production, the annual output value will be nearly 3.5 billion yuan, and an investment company and a trade center in North Ch ina will be founded.

Great Wall Automotive Finance Increases Its Capital


Recently, Tianjin Great Wall Automotive Finance Co., Ltd. has been approved to increase its capital by 4.5 billion yuan, with the total registered capital reaching 6.6 billion yuan. Tianjin Great Wall Automotive Finance Co., Ltd. is China’s first auto finance company with shares mostly held by private capital.


World-leading Biopharmaceutical Project Settled down in TEDA


On January 10, TEDA signed a cooperation agreement with Suzhou Ribo Life Science Co., Ltd. and Asymchem Labs. Ribo Life Science will cooperate with Tianjin Haihe Asymchem Biopharmaceutical Industry Innovation Investment Fund to invest in the construction of a kilogram-scale commercial production base for small nucleic acid crude drug in TEDA West, benefiting the commercialization of small nucleic acid drug in China.

DegludecPlus Produced in TEDA Added to China’s Medicare List


DegludecPlus, the first double insulin in the world, has been added to the national medical insurance reimbursement list, and will be officially used nationwide on March 1, 2021. DegludecPlus is developed and produced by Novo Nordisk (China) Pharmaceuticals Co., Ltd. in TEDA.

Tianjin Time-honored Company Starts to Build New Plant in TEDA


Recently, the project of 50,000 tons of paint and 20,000 tons of resin in Nangang Industrial Zone officially started. The project is invested and constructed by Tianjin Beacon Coatings Co., Ltd., with a total investment of about 350 million yuan. The trial production will be in May 2022, and the estimated annual output value will be about 900 million yuan.

TOP
Website Identification Code: 1201160062

Are you sure you want to leave this page?